Thrifters, consignment lovers, and bargain hunters, mark your calendars for the Junior League of Boca Raton’s two-day Boca ...

These sites and apps can help you save money on clothes and products your kids will soon outgrow, and they help the ...

In the new filing, Lilly says it wants to wade into the legal proceedings to “protect its interests and help bring this suit to a swift end.” The company’s lawyers further contend that OFA ...

Lilly seeks to protect interests in compounded drug case FDA affirms no shortage of tirzepatide drugs Compounded versions cheaper, often not covered by insurers Jan 2 (Reuters) - Eli Lilly (LLY.N ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for ... [+] health insurers, employers and government health programs who cover it in 2025.

Gary Cohn, 72, formerly of Philadelphia, an Inquirer alum who went on to win a Pulitzer Prize at the Baltimore Sun during a decades-long career devoted to investigative reporting, died Monday, Dec. 23 ...

The number of flats sold on the resale market for a million dollars or more has reached a record high and is unlikely to slow down in 2025, according to property experts. Real estate agency ERA ...

In the time since, though, some analysts have said the reaction is overblown, particularly for weight-loss drugmakers like Wegovy, and Ozempic maker Novo Nordisk and Zepbound maker Eli Lilly.

Enter Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), the makers behind blockbuster glucagon-like peptide-1 (GLP-1) agonists such as Mounjaro, Zepbound, Ozempic, and Wegovy -- all of which are ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved and that specialty pharmacies and online companies need to stop ...

The RealReal, an online marketplace for resale luxury goods, has added a local location to its brick-and-mortar lineup, has opened a store in Montrose, its first in Houston and second in Texas.

November 2024 proved to be an eventful month for the condo resale market. Although transaction volumes saw a modest decline, primarily due to the year’s largest wave of new project launches, resale ...